<DOC>
	<DOCNO>NCT00889018</DOCNO>
	<brief_summary>The purpose study determine whether increase dose carboplatin treatment advance intraocular ( group C D ) retinoblastoma help avoid radiotherapy improves rate globe salvage .</brief_summary>
	<brief_title>Trial Comparing Two Carboplatin Doses Groups C D Intraocular Retinoblastoma</brief_title>
	<detailed_description>Chemoreduction become important method management retinoblastoma . This technique employ effort avoid enucleation external beam radiotherapy ( EBRT ) child intraocular retinoblastoma , especially bilateral disease . Although ideal regimen chemoreduction determine , author use combination vincristine , etoposide carboplatin 2- 6 cycle along local treatment include cryotherapy , laser photocoagulation , thermotherapy plaque radiotherapy . Chemoreduction along local treatment show high treatment success group A B retinoblastoma allow globe salvage without need EBRT . But globe salvage rate remain low group C D , mostly need enucleation , EBRT large number case . In bilateral retinoblastoma one eye already lose owe enucleation eye advance retinoblastoma ( group C/D ) globe salvage assume significant role overall treatment . Recurrences vitreous seed sub retinal seed main cause treatment failure chemoreduction local treatment , ultimately require enucleation EBRT . The recurrence vitreous subretinal seed necessarily mean tumor resistance , may reflect inadequate penetration chemotherapeutic agent relatively avascular site i.e vitreous cavity subretinal space . The penetration site could enhance ( ) increase dose intravenous chemotherapeutic agent . The IInd Toronto protocol start 2000 explores option . The initial report encourage use high dos chemotherapy combination cyclosporin A . Therefore effect high dose chemotherapy globe salvage rate group C D evaluate independent factor . ( b ) Periocular carboplatin injection proven deliver much high level drug vitreous cavity , several study reveal local side effect apparently harmless technique.The National Collaborative Retinoblastoma Study fund Children 's oncology group plan carry single arm trial 6 cycle systemic high dose chemotherapy subtenon carboplatin injection group C D retinoblastoma . ( c ) Use Cryotherapy/thermotherapy along chemotherapy , show increase penetration chemotherapeutic agent vitreous cavity probably disrupt blood retinal barrier . Shield 's et al already show 6 cycle chemotherapy regimen achieves well long-term control vitreous subretinal seed compare 2 cycle regimen . We plan study compare two different dose schedule carboplatin compare rate globe salvage group C D retinoblastoma also evaluate effect subtenon Carboplatin injection case fail respond primary chemotherapy .</detailed_description>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>All new case retinoblastoma group C D tumor per ICRB ( International classification retinoblastoma , Table 2 ) present Rajendra Prasad Centre Ophthalmic Sciences first 2 year study period Biomicroscopic evidence iris neovascularization Neovascular glaucoma Tumor invasion anterior chamber , iris , optic nerve , choroid , extraocular tissue document clinical , ultrasonographic , neuroimaging modality . Systemic exclusion criterion include : evidence systemic metastasis prior chemotherapy prior treatment retinoblastoma , inadequate renal hepatic function</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>intraocular retinoblastoma</keyword>
	<keyword>chemotherapy</keyword>
</DOC>